Sublingual grass pollen allergen: Preliminary Phase IIa data

Preliminary data from the placebo-controlled Phase IIa GSL103 trial in 60 evaluable

Read the full 125 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE